Markets & Investing
SGX welcomes Maybank Kim Eng Securities as Catalist full sponsor
It's the third company added this year.
SGX welcomes Maybank Kim Eng Securities as Catalist full sponsor
It's the third company added this year.
Singapore Exchange's market turnover slips 8% in September
The month lacks new Mainboard or Catalist listing.
Here's one reason to stay bullish on Singapore Post despite corporate governance woes
Over $600m global investments since 2011 will finally bear fruit.
Singapore hedge funds mired in slowest growth in three years: Bloomberg
It grew 11% to $119b in 2015.
Phillip Capital Management unveils maiden Asia Pacific REITs ETF in Singapore
It aims to provide low-cost access to APAC REITs.
Chinese consortium to buy Singapore's biggest reinsurance firm ACR
The deal is worth about $1.4 billion.
Singapore equity capital market volume soars 86% despite slump in regional activity
Southeast Asia deals declined by 16%.
Singapore investors likely to keep getting the jitters in October
Earnings recession, weak economy continue to dampen outlook.
Daily Markets Briefing: STI up 0.05%
Pullback on Wall Street could hurt the local bourse today.
Is Singapore's startup funding fever starting to cool down?
Potential investors are giving unicorns the cold shoulder treatment.
Daily Markets Briefing: STI down 0.56%
But expect some support to the local bourse this morning.
Are passive investments making financial advisors jittery?
They are expected to constitute 41.7% of investors’ portfolio.
Singapore IPO market remains healthy despite depressed global activity
Singapore is second top dealmaker in 3Q among Asean peers.
Singapore knocks Hong Kong off top spot in corporate governance ranking
Check out which countries made the cut.
Daily Markets Briefing: STI up 0.97%
Local sentiment likely to be fairly cautious.
All is set for Singapore's first healthcare company to have an IPO this year
Fullerton Health offers 140.3 million shares.
SGX strengthens measures to deter market misconduct
Two initiatives were introduced.